Abstract
A three-dimensional model of the human Na+/Cl−-dependent γ-aminobutyric acid (GABA) transporter hGAT-1 was developed by homology modeling and refined by subsequent molecular modeling using the crystal structure of a bacterial homologue leucine transporter from Aquifex aeolicus (LeuTAa) as the template. Protein structure quality checks show that the resulting structure is particularly suited for the analysis of the substrate binding pocket and virtual screening experiments. Interactions of GABA and the substrate binding pocket were investigated using docking studies. The difference of 6 out of 13 substrate interacting side chains between hGAT-1 and LeuTAa lead to the different substrate preference which can be explained using our three-dimensional model of hGAT-1. In particular the replacement of serine 256 and isoleucine 359 in LeuTAa with glycine and threonine in hGAT-1 seems to facilitate the selection of GABA as the main substrate by changing the hydrogen bonding pattern in the active site to the amino group of the substrate. For a set of 12 compounds flexible docking experiments were performed using LigandFit in combination with the Jain scoring function. With few exceptions the obtained rank order of potency was in line with experimental data. Thus, the method can be assumed to give at least a rough estimate of the potency of the potential of GABA uptake inhibitors.
References
Nelson H, Mandiyan S, Nelson N (1990) FEBS Lett 269:181–184
Borden LA, Smith KE, Hartig PR, Branchek TA, Weinshank RL (1992) J Biol Chem 267:21098–21104
Guastella J, Nelson N, Nelson H, Czyzyk L, Keynan S, Miedel MC, Davidson N, Lester HA, Kanner BI (1990) Science 249:1303–1306
Masson J, Sagné C, Hamon M, Mestikawy SE (1999) Pharmacol Rev 51:439–464
Chen N, Reith MEA, Quick MW (2004) Pflugers Arch 447:519–531
Gether U, Andersen PH, Larsson OM, Schousboe A (2006) Trends Pharmacol Sci 27:375–383
Yamashita A, Singh SK, Kawate T, Jin Y, Gouaux E (2005) Nature 437:215–223
Dodd JR, Christi DL (2007) J Biol Chem 282:15528–15533
Beuming T, Shi L, Javitch JA, Weinstein H (2006) Mol Pharmacol 70:1630–1642
Palló A, Bencsura A, Héja L, Beke T, Perczel A, Kardos J, Simon A (2007) Biochem Biophys Res Commun 364:952–958
Boeckmann B, Bairoch A, Apweiler R, Blatter M, Estreicher A, Gasteiger E, Martin MJ, Michoud K, O'Donovan C, Phan I, Pilbout S, Schneider M (2003) Nucleic Acids Res 31:365–370
Bernstein FC, Koetzle TF, Williams GJB, Meyer EF Jr, Brice MD, Rodgers JR, Kennard O, Shimanouchi T, Tasumi M (1977) J Mol Biol 112:535–542
Sali A, Blundell TL (1993) J Mol Biol 234:779–815
van der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJC (2005) J Comput Chem 26:1701–1718
Hess B, Kutzner C, van der Spoel D (2008) Lindahl E 4:435–447
Scott WRP, Hunenberger PH, Tironi IG, Mark AE, Billeter SR, Fennen J, Torda AE, Huber T, Kruger P, van Gunsteren WF (1999) J Phys Chem A 103:3596–3607
Essmann U, Perera L, Berkowitz ML, Darden T, Lee H, Pedersen LG (1995) J Chem Phys 103:8577–8592
Laskowski RA, MacArthur MW, Moss DS, Thornton JM (1993) J App Cryst 26:283–291
Lüthy R, Bowie JU, Eisenberg D (1992) Nature 356:83–85
Maple JR, Hwang MJ, Stockfisch TP, Dinur U, Waldman M, Ewig CS, Hagler AT (1994) J Comput Chem 15:162–182
Venkatachalam CM, Jiang X, Oldfield T, Waldman M (2003) J Mol Graph Model 2:289–307
Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ (1998) J Comput Chem 19:1639–1662
Moustakas DT, Lang PT, Pegg S, Pettersen E, Kuntz ID, Brooijmans N, Rizzo RC (2006) J Comput-Aided Mol Design 20:601–619
Zsoldos Z, Reid D, Simon A, Sadjad SB, Johnson AP (2007) J Mol Graph Model 26:198–212
Rarey M, Kramer B, Lengauer T, Klebe G (1996) J Mol Biol 261:470–489
Jones G, Willet P, Glen RC, Leach AR, Taylor R (1997) J Mol Biol 267:727–748
Jain AN (1996) J Comput-Aided Mol Design 10:427–440
Kanner B, Zomot E (2008) Chem Rev 108(5):1654–1668
Kragler A, Höfner G, Wanner KT (2008) Eur J Med Chem 43:2404–2411
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wein, T., Wanner, K.T. Generation of a 3D model for human GABA transporter hGAT-1 using molecular modeling and investigation of the binding of GABA. J Mol Model 16, 155–161 (2010). https://doi.org/10.1007/s00894-009-0520-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00894-009-0520-3